DECHRA VETERINARY PRODUCTS A/S: Financial statements 2023
CVR: 10114241
DECHRA VETERINARY PRODUCTS A/S (CVR 10114241) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 2,513,140,000 and a net result of DKK 129,704,000 compared with DKK 157,581,000 the year before. That is an increase of 6.1% compared with the year before. The profit margin was 5.2%. Equity amounted to DKK 688,900,000. The solvency ratio was 50.8%. The company had 110 employees in the financial year.
- Revenue
- 2,513,140,000 kr.
- Gross Profit
- 238,874,000 kr.
- Profit/Loss
- 129,704,000 kr.
- Equity
- 688,900,000 kr.
- Total Assets
- 1,356,395,000 kr.
- Employees
- 110
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | 2.5 mia. | 238.9 mio. | 129.7 mio. | 688.9 mio. | 110 |
| 2022 | 2.4 mia. | 255.8 mio. | 157.6 mio. | 560.4 mio. | 108 |
| 2021 | 2.1 mia. | 192.2 mio. | 98.3 mio. | 403.1 mio. | 98 |
| 2020 | 1.6 mia. | 112 mio. | 23.3 mio. | 302.8 mio. | 91 |
| 2019 | 1.4 mia. | 193.6 mio. | 96.5 mio. | 555.8 mio. | 76 |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
As of November 27, 2023, Paul Nicholas Sandland has joined the board of directors of DECHRA VETERINARY PRODUCTS A/S.
As of November 27, 2023, Anthony Gerard Griffin has left the board of directors of DECHRA VETERINARY PRODUCTS A/S.
About DECHRA VETERINARY PRODUCTS A/S
DECHRA VETERINARY PRODUCTS A/S is a Danish company of the type Aktieselskab based in Uldum, founded in 1986. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VETXX A/S and LEO ANIMAL HEALTH A/S. The management consists of Ian Machan Mackellar. The company is owned by Dechra Pharmaceuticals Limited. The company has 78 employees. In 2025, the company reported revenue of DKK 2,875,016,000 and a net result of DKK 189,967,000 compared with DKK 116,939,000 the year before. Equity amounted to DKK 571,636,000.
